Net price index for cancer products in developed markets 2014

Published by Statista Research Department, May 22, 2014
This statistic shows the net price index for oncologic drugs indexed to the U.S. MSP, as of 2014. In that year, cancer drugs cost 79 percent of the U.S. price when indexed to the U.S. MSP. Oncology spending remains mostly in the United States and the five leading EU-countries.

Net price index for oncology products in selected developed markets as of 2014*

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

May 2014

Region

Europe, United States

Survey time period

As of 2014

Supplementary notes

* Net price indexed to U.S. MSP.
All countries in the E.U. feature discount mechanisms at the national level, with those in Italy being the most varied. Discount mechanisms are less prevalent at the regional level. At the local level, non-publically disclosed contracting arrangements are in place for all countries in the E.U.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Oncology "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Oncology

Cancer facts

5

Oncology market

6

Companies

7

Cancer drugs

5

Research and development

6

Immuno-oncology

5

Treatment types

5

Physicians and patients

8

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

RocheGlobal pharmaceutical industryJohnson & JohnsonNovartisCancer in the U.S.
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.